Cardio-renal interaction: Impact of renal function and anemia on the outcome of chronic heart failure

Hisashi Kimura, Shinya Hiramitsu, Kenji Miyagishima, Kazumasa Mori, Ryuji Yoda, Shigeru Kato, Yasuchika Kato, Shin Ichiro Morimoto, Hitoshi Hishida, Yukio Ozaki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The purpose of this study is to investigate the effects of renal function and anemia on the outcome of chronic heart failure (CHF). We targeted 711 consecutive patients who were hospitalized at the Division of Cardiology of Fujita Health University Hospital during a 5-year period. The subjects were divided into four groups according to their estimated glomerular filtration rate (e-GFR) calculated using the Modification of Diet in Renal Disease (MDRD) formula. Intergroup comparisons were conducted for underlying heart diseases, clinical findings at the time of hospitalization, treatment, and outcome. Moreover, the patients were divided into two groups according to their serum hemoglobin concentration at the time of hospitalization, using 12.0 g/dl as the dividing point, to study the effects of anemia on the outcome. In the group with decreased renal function, the average age was higher, and ischemic heart disease and associated conditions such as hypertension and diabetes mellitus were observed in most of the patients. In addition, the rate of anemia development and the plasma B-type natriuretic peptide concentration were also high. The greater the deterioration in renal function, the poorer the outcome became (P < 0.0001). Chronic heart failure complicated by anemia showed an especially poor outcome (P < 0.0001). As this study showed that renal function and anemia significantly affected the outcome of CHF, it is clear that the preservation of renal function and the management of anemia are important in addition to the conventional treatments for CHF.

Original languageEnglish
Pages (from-to)306-312
Number of pages7
JournalHeart and Vessels
Volume25
Issue number4
DOIs
Publication statusPublished - 01-07-2010

Fingerprint

Anemia
Heart Failure
Kidney
Hospitalization
Diet Therapy
Brain Natriuretic Peptide
Cardiology
Glomerular Filtration Rate
Myocardial Ischemia
Heart Diseases
Diabetes Mellitus
Hemoglobins
Hypertension
Health
Serum
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Kimura, Hisashi ; Hiramitsu, Shinya ; Miyagishima, Kenji ; Mori, Kazumasa ; Yoda, Ryuji ; Kato, Shigeru ; Kato, Yasuchika ; Morimoto, Shin Ichiro ; Hishida, Hitoshi ; Ozaki, Yukio. / Cardio-renal interaction : Impact of renal function and anemia on the outcome of chronic heart failure. In: Heart and Vessels. 2010 ; Vol. 25, No. 4. pp. 306-312.
@article{c48fd76a4e0a4acfbe90dc31773a2e28,
title = "Cardio-renal interaction: Impact of renal function and anemia on the outcome of chronic heart failure",
abstract = "The purpose of this study is to investigate the effects of renal function and anemia on the outcome of chronic heart failure (CHF). We targeted 711 consecutive patients who were hospitalized at the Division of Cardiology of Fujita Health University Hospital during a 5-year period. The subjects were divided into four groups according to their estimated glomerular filtration rate (e-GFR) calculated using the Modification of Diet in Renal Disease (MDRD) formula. Intergroup comparisons were conducted for underlying heart diseases, clinical findings at the time of hospitalization, treatment, and outcome. Moreover, the patients were divided into two groups according to their serum hemoglobin concentration at the time of hospitalization, using 12.0 g/dl as the dividing point, to study the effects of anemia on the outcome. In the group with decreased renal function, the average age was higher, and ischemic heart disease and associated conditions such as hypertension and diabetes mellitus were observed in most of the patients. In addition, the rate of anemia development and the plasma B-type natriuretic peptide concentration were also high. The greater the deterioration in renal function, the poorer the outcome became (P < 0.0001). Chronic heart failure complicated by anemia showed an especially poor outcome (P < 0.0001). As this study showed that renal function and anemia significantly affected the outcome of CHF, it is clear that the preservation of renal function and the management of anemia are important in addition to the conventional treatments for CHF.",
author = "Hisashi Kimura and Shinya Hiramitsu and Kenji Miyagishima and Kazumasa Mori and Ryuji Yoda and Shigeru Kato and Yasuchika Kato and Morimoto, {Shin Ichiro} and Hitoshi Hishida and Yukio Ozaki",
year = "2010",
month = "7",
day = "1",
doi = "10.1007/s00380-009-1201-y",
language = "English",
volume = "25",
pages = "306--312",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "4",

}

Kimura, H, Hiramitsu, S, Miyagishima, K, Mori, K, Yoda, R, Kato, S, Kato, Y, Morimoto, SI, Hishida, H & Ozaki, Y 2010, 'Cardio-renal interaction: Impact of renal function and anemia on the outcome of chronic heart failure', Heart and Vessels, vol. 25, no. 4, pp. 306-312. https://doi.org/10.1007/s00380-009-1201-y

Cardio-renal interaction : Impact of renal function and anemia on the outcome of chronic heart failure. / Kimura, Hisashi; Hiramitsu, Shinya; Miyagishima, Kenji; Mori, Kazumasa; Yoda, Ryuji; Kato, Shigeru; Kato, Yasuchika; Morimoto, Shin Ichiro; Hishida, Hitoshi; Ozaki, Yukio.

In: Heart and Vessels, Vol. 25, No. 4, 01.07.2010, p. 306-312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cardio-renal interaction

T2 - Impact of renal function and anemia on the outcome of chronic heart failure

AU - Kimura, Hisashi

AU - Hiramitsu, Shinya

AU - Miyagishima, Kenji

AU - Mori, Kazumasa

AU - Yoda, Ryuji

AU - Kato, Shigeru

AU - Kato, Yasuchika

AU - Morimoto, Shin Ichiro

AU - Hishida, Hitoshi

AU - Ozaki, Yukio

PY - 2010/7/1

Y1 - 2010/7/1

N2 - The purpose of this study is to investigate the effects of renal function and anemia on the outcome of chronic heart failure (CHF). We targeted 711 consecutive patients who were hospitalized at the Division of Cardiology of Fujita Health University Hospital during a 5-year period. The subjects were divided into four groups according to their estimated glomerular filtration rate (e-GFR) calculated using the Modification of Diet in Renal Disease (MDRD) formula. Intergroup comparisons were conducted for underlying heart diseases, clinical findings at the time of hospitalization, treatment, and outcome. Moreover, the patients were divided into two groups according to their serum hemoglobin concentration at the time of hospitalization, using 12.0 g/dl as the dividing point, to study the effects of anemia on the outcome. In the group with decreased renal function, the average age was higher, and ischemic heart disease and associated conditions such as hypertension and diabetes mellitus were observed in most of the patients. In addition, the rate of anemia development and the plasma B-type natriuretic peptide concentration were also high. The greater the deterioration in renal function, the poorer the outcome became (P < 0.0001). Chronic heart failure complicated by anemia showed an especially poor outcome (P < 0.0001). As this study showed that renal function and anemia significantly affected the outcome of CHF, it is clear that the preservation of renal function and the management of anemia are important in addition to the conventional treatments for CHF.

AB - The purpose of this study is to investigate the effects of renal function and anemia on the outcome of chronic heart failure (CHF). We targeted 711 consecutive patients who were hospitalized at the Division of Cardiology of Fujita Health University Hospital during a 5-year period. The subjects were divided into four groups according to their estimated glomerular filtration rate (e-GFR) calculated using the Modification of Diet in Renal Disease (MDRD) formula. Intergroup comparisons were conducted for underlying heart diseases, clinical findings at the time of hospitalization, treatment, and outcome. Moreover, the patients were divided into two groups according to their serum hemoglobin concentration at the time of hospitalization, using 12.0 g/dl as the dividing point, to study the effects of anemia on the outcome. In the group with decreased renal function, the average age was higher, and ischemic heart disease and associated conditions such as hypertension and diabetes mellitus were observed in most of the patients. In addition, the rate of anemia development and the plasma B-type natriuretic peptide concentration were also high. The greater the deterioration in renal function, the poorer the outcome became (P < 0.0001). Chronic heart failure complicated by anemia showed an especially poor outcome (P < 0.0001). As this study showed that renal function and anemia significantly affected the outcome of CHF, it is clear that the preservation of renal function and the management of anemia are important in addition to the conventional treatments for CHF.

UR - http://www.scopus.com/inward/record.url?scp=77956053939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956053939&partnerID=8YFLogxK

U2 - 10.1007/s00380-009-1201-y

DO - 10.1007/s00380-009-1201-y

M3 - Article

C2 - 20676839

AN - SCOPUS:77956053939

VL - 25

SP - 306

EP - 312

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 4

ER -